Gold keeps recovery moves from $1,864 despite recently easing from $1,896.
Moderna’s vaccine trials keep markets hopeful despite virus woes.
Brexit news, updates from Johnson & Johnson offer the latest positive push.
Risk catalysts to keep the driver’s seat amid a light calendar. Gold picks up bids around $1,888, up 0.07% on a day, during the early Tuesday’s Asian session. The yellow metal recently gained, after the initial $30 drop, as global markets turned optimistic on the coronavirus (COVID-19) vaccine. Also favoring the risk-on mood could be the Brexit news as well as the US dollar weakness. J&J, Moderna keeps markets upbeat… Having earlier heard that Moderna’s vaccine has a 94.5% effective rate and is easy to distribute, AP News recently came out with the headlines suggesting the start of the two-dose vaccine trials from Johnson and Johnson. Global markets are optimistic to find a […]
November 17, 2020 Published by StockMan